RecruitingPhase 3NCT06736574
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Sponsor: Cytokinetics
Kansas City, KS · Overland Park, KS · +86 more sites
2 recruiting heart failure studies with a site in Overland Park, KS.
Sponsor: Cytokinetics
Kansas City, KS · Overland Park, KS · +86 more sites
Sponsor: Kansas City Heart Rhythm Research Foundation
Overland Park, KS
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.